Sietse J. Luk
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
PRAME Expression: A Target for Cancer Immunotherapy and a Prognostic Factor in Uveal Melanoma.
Journal: Investigative ophthalmology & visual science
Published: December 27, 2023
Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: November 16, 2023
Activated HLA-DR+CD38+ Effector Th1/17 Cells Distinguish Crohn's Disease-associated Perianal Fistulas from Cryptoglandular Fistulas.
Journal: Inflammatory bowel diseases
Published: October 05, 2023
Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: April 19, 2023
VISTA Expression on Cancer-Associated Endothelium Selectively Prevents T-cell Extravasation.
Journal: Cancer immunology research
Published: September 23, 2022
Imaging mass cytometry reveals the prominent role of myeloid cells at the maternal-fetal interface.
Journal: iScience
Published: August 26, 2021
Visual cohort comparison for spatial single-cell omics-data.
Journal: IEEE transactions on visualization and computer graphics
Published: October 28, 2020
PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapy.
Journal: Oncoimmunology
Published: June 14, 2018
PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma.
Journal: JAMA ophthalmology
Published: April 28, 2017
Refractive outcome of combined phacoemulsification and endoscopic cyclophotocoagulation.
Journal: International ophthalmology
Published: March 07, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026